Cargando…
Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning()
Neoadjuvant treatment (NAT) has become an option in early stage (stage I-II) breast cancer (EBC). New advances in systemic and targeted therapies have increased rates of pathologic complete response increasing the number of patients undergoing NAT. Clear benefits of NAT are downstaging the tumor and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097809/ https://www.ncbi.nlm.nih.gov/pubmed/34996668 http://dx.doi.org/10.1016/j.breast.2021.12.019 |